191
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Chimeric liposomes decorated with P407: an alternative biomaterial for producing stealth nano-therapeutics

, , & ORCID Icon
Pages 83-91 | Received 25 May 2021, Accepted 27 Aug 2021, Published online: 29 Nov 2021

References

  • Aggarwal, P., et al., 2009. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Advanced drug delivery reviews, 61 (6), 428–437.
  • Ahmed, K.S., et al., 2020. Liposome-based codelivery of celecoxib and doxorubicin hydrochloride as a synergistic dual-drug delivery system for enhancing the anticancer effect. Journal of liposome research, 30 (3), 285–296.
  • Ahmed, S., et al., 2019. Conception of nanosized hybrid liposome/poloxamer particles to thicken the interior core of liposomes and delay hydrophilic drug delivery. International journal of pharmaceutics, 567, 118488.
  • Bodratti, A.M., and Alexandridis, P., 2018. Formulation of poloxamers for drug delivery. Journal of functional biomaterials, 9 (1), 11.
  • Bulbake, U., et al., 2017. Liposomal formulations in clinical use: an updated review. Pharmaceutics, 9 (2), 1–33.
  • Castile, J.D., Taylor, K.M.G., and Buckton, G., 1999. A high sensitivity differential scanning calorimetry study of the interaction between poloxamers and dimyristoylphosphatidylcholine and dipalmitoylphosphatidylcholine liposomes. International journal of pharmaceutics, 182 (1), 101–110.
  • Castile, J.D., Taylor, K.M.G., and Buckton, G., 2001. The influence of incubation temperature and surfactant concentration on the interaction between dimyristoylphosphatidylcholine liposomes and poloxamer surfactants. International journal of pharmaceutics, 221 (1–2), 197–209.
  • Chandaroy, P., et al., 2002. Utilizing temperature-sensitive association of Pluronic F-127 with lipid bilayers to control liposome-cell adhesion. Biochimica et biophysica acta, 1559 (1), 32–42.
  • Chatterjee, S., et al., 2019. Dual-responsive (pH/temperature) pluronic F-127 hydrogel drug delivery system for textile-based transdermal therapy. Scientific reports, 9 (1), 11658.
  • Cheng, C.-Y., et al., 2012. Nature of interactions between PEO-PPO-PEO triblock copolymers and lipid membranes: (II) role of hydration dynamics revealed by dynamic nuclear polarization. Biomacromolecules, 13 (9), 2624–2633.
  • Chung, C.K., et al., 2020. Doxorubicin loaded poloxamer thermosensitive hydrogels: chemical, pharmacological and biological evaluation. Molecules, 25 (9), 1–15.
  • Cohen, J., and Kupferschmidt, K., 2020. As vaccines emerge, a global waiting game begins. Science (New York), 370 (6523), 1385–1387.
  • Demetzos, C., 2016. Pharmaceutical nanotechnology. Fundamentals and practical applications. 1st ed. Singapore: ADIS.
  • dos Santos, C.C.P., et al., 2020. Therapeutic efficacy of a mixed formulation of conventional and PEGylated liposomes containing meglumine antimoniate, combined with allopurinol, in dogs naturally infected with Leishmania infantum. Antimicrobial agents and chemotherapy, 64 (7):e00234–e00220.
  • Dumortier, G., et al., 2006. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharmaceutical research, 23 (12), 2709–2728.
  • El-Sayed, A., and Kamel, M., 2020. Advances in nanomedical applications: diagnostic, therapeutic, immunization, and vaccine production. Environmental science and pollution research international, 27 (16), 19200–19213.
  • Estanqueiro, M., et al., 2015. Nanotechnological carriers for cancer chemotherapy: the state of the art. Colloids and surfaces. B, biointerfaces, 126, 631–648.
  • Eygeris, Y., et al., 2020. Deconvoluting lipid nanoparticle structure for messenger RNA delivery. Nano letters, 20 (6), 4543–4549.
  • Farzaneh, H., et al., 2018. A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: from liposomal preparation to therapy. International journal of pharmaceutics, 551 (1–2), 300–308.
  • Firestone, M.A., Wolf, A.C., and Seifert, S., 2003. Small-angle X-ray scattering study of the interaction of poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) triblock copolymers with lipid bilayers. Biomacromolecules, 4 (6), 1539–1549.
  • Garvey, L.H., and Nasser, S., 2021. Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit? British journal of anaesthesia, 126 (3), e106–e108.
  • Heuts, J., et al., 2018. Cationic liposomes: a flexible vaccine delivery system for physicochemically diverse antigenic peptides. Pharmaceutical research, 35 (11), 207.
  • Hezaveh, S., et al., 2012. Understanding the interaction of block copolymers with DMPC lipid bilayer using coarse-grained molecular dynamics simulations. The journal of physical chemistry. B, 116 (49), 14333–14345.
  • Ishida, T., Harashima, H., and Kiwada, H., 2001. Interactions of liposomes with cells in vitro and in vivo: opsonins and receptors. Current drug metabolism, 2 (4), 397–409.
  • Jang, E.J., et al., 2017. 2-Hydroxyoleic acid-inserted liposomes as a multifunctional carrier of anticancer drugs. Drug delivery, 24 (1), 1587–1597.
  • Johnsson, M., et al., 1999. Effect of PEO-PPO-PEO triblock copolymers on structure and stability of phosphatidylcholine liposomes. Languir, 15 (19), 6314–6325.
  • Johnsson, M., et al., 2001. Adsorption of a PEO-PPO-PEO triblock copolymer on small unilamellar vesicles: equilibrium and kinetic properties and correlation with membrane permeability Markus. Langmuir, 17 (13), 3902–3911.
  • Kong, L., et al., 2020. Transferrin-modified osthole PEGylated liposomes travel the blood-brain barrier and mitigate Alzheimer's disease-related pathology in APP/PS-1 mice. International journal of nanomedicine, 15, 2841–2858.
  • Kostarelos, K., Tadros, T.F., and Luckham, P.F., 1999. Physical conjugation of (Tri-) block copolymers to liposomes toward the construction of sterically stabilized vesicle. Langmuir, 15 (2), 369–376.
  • Kozma, G.T., et al., 2020. Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals. Advanced drug delivery reviews, 154–155, 163–175.
  • Kraft, J.C., et al., 2014. Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. Journal of pharmaceutical sciences, 103 (1), 29–52.
  • Kulkarni, J.A., et al., 2019. On the role of helper lipids in lipid nanoparticle formulations of siRNA. Nanoscale, 11 (45), 21733–21739.
  • Kyrili, A., et al., 2017. Design and development of pH-sensitive liposomes by evaluating the thermotropic behavior of their chimeric bilayers. Journal of thermal analysis and calorimetry, 127 (2), 1381–1392.
  • Li, J., et al., 2015. A review on phospholipids and their main applications in drug delivery systems. Asian journal of pharmaceutical sciences, 10 (2), 81–98.
  • Li, Z., et al., 2020. Liposomes consisting of pluronic F127 and phospholipid: Effect of matrix on morphology, stability and curcumin delivery. Journal of Dispersion science and technology, 41 (2), 207–213.
  • Li, Z., et al., 2021. Effect of pluronic block composition on the structure, stability, and cytotoxicity of liposomes. Journal of dispersion science and technology, 42 (11), 1651–1659.
  • Minnelli, C., et al., 2018. A Poloxamer-407 modified liposome encapsulating epigallocatechin-3-gallate in the presence of magnesium: characterization and protective effect against oxidative damage. International journal of pharmaceutics, 552 (1–2), 225–234.
  • Mishra, S.K., and Tripathi, T., 2021. One year update on the COVID-19 pandemic: where are we now? Acta tropica, 214, 105778.
  • Oliver, S., et al., 2020. The advisory committee on immunization practices' interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine – United States, December 2020. Morbidity and mortality weekly report, 69 (50), 1922–1924.
  • Patel, S., et al., 2020. Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA. Nature communications, 11 (1), 983.
  • Pandelidou, M., et al., 2011. Preparation and characterization of lyophilised EGG PC liposomes incorporating curcumin and evaluation of its activity against colorectal cancer cell lines. Journal of nanoscience and nanotechnology, 11 (2), 1259–1266.
  • Papageorgiou, F., et al., 2019. Physicochemical study of the protein-liposome interactions: influence of liposome composition and concentration on protein binding. Journal of liposome research, 29 (4), 313–321.
  • Pembouong, G., et al., 2011. A comprehensive study in triblock copolymer membrane interaction. Journal of controlled release, 151 (1), 57–64.
  • Pippa, N., et al., 2013. PEO-b-PCL-DPPC chimeric nanocarriers: self-assembly aspects in aqueous and biological media and drug incorporation. Soft matter., 9 (15), 4073–4082.
  • Pippa, N., et al., 2016. Calorimetric study on pH-responsive block copolymer grafted lipid bilayers: rational design and development of liposomes. Journal of liposome research, 26 (3), 211–220.
  • Smith, D.M., Simon, J.K., and Baker, J.R., 2013. Applications of nanotechnology for immunology. Nature reviews immunology, 13 (8), 592–605.
  • Vangala, V., et al., 2020. Combating glioblastoma by codelivering the small-molecule inhibitor of STAT3 and STAT3siRNA with α5β1 integrin receptor-selective liposomes. Molecular pharmaceutics, 17 (6), 1859–1874.
  • Wu, G., and Lee, K.Y.C. , 2009. Interaction of poloxamers with liposomes: an isothermal titration calorimetry study. The journal of physical chemistry B, 113 (47), 15522–15531.
  • Yanez Arteta, M., et al., 2018. Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles. Proceedings of the national academy of sciences of the United States of America, 115 (15), E3351–E3360.
  • Zhang, W., et al., 2020. Light-triggered release of conventional local anesthetics from a macromolecular prodrug for on-demand local anesthesia. Nature communications, 11 (1), 2323.
  • Zhu, Q., et al., 2013. Pluronic F127-modified liposome-containing tacrolimus-cyclodextrin inclusion complexes: improved solubility, cellular uptake and intestinal penetration. The journal of pharmacy and pharmacology, 65 (8), 1107–1117.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.